118 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
is for a sum payable in respect of taxes, or other charges of a like nature or is in respect of a fine or other penalty or otherwise based on a foreign law … , imposts, fees, assessments or governmental charges of whatever nature (other than taxes on net income) unless the Company is or becomes required
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
payable to a regulatory authority by way of a penalty in respect of non-compliance with any requirement of a regulatory nature (however arising), or any … of the material terms of the ADSs and of your material rights as an owner of ADSs. Please remember that summaries by their nature lack the precision
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
financial statements.
MEREO BIOPHARMA GROUP PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. Nature of business
Mereo … and accrued expenses approximate their fair value due to the short-term nature of those financial instruments.
The following table summarizes the Company’s
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the nature and extent of disclosures in the financial statements and the accompanying notes. The Audit and Risk Committee also reviewed the progress
10-K
2023 FY
EX-4.2
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
as an owner of ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights
10-K
k031m3vmca40qa98
27 Mar 24
Annual report
5:20pm
10-K
EX-10.30
c4jfk
27 Mar 24
Annual report
5:20pm
6-K
EX-3.1
m6vna4h 7s7
18 Dec 23
Current report (foreign)
4:10pm
6-K
EX-99.2
e4stq 1ap1a42
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
smrbv3m1 o1qwau1
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
nef6dg7hs6n1moetof5
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.1
etkd64z7
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
8qld19z9jj6yjyjyl py
17 May 22
Current report (foreign)
8:26am
6-K
EX-3.1
xyf ymkgrz
17 May 22
Current report (foreign)
8:26am